DERMATOFIBROSARCOMA PROTUBERANS

DERMATOFIBROSARCOMA PROTUBERANS was reported 96 times

DERMATOFIBROSARCOMA PROTUBERANS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Leptin Analog [EPC] 1 0.0008
1 Antimycobacterial [EPC] 2 0.0001
2 Purine Antimetabolite [EPC] 7 0.0001
3 Integrin Receptor Antagonist [EPC] 6 0.0001
4 Interleukin-23 Antagonist [EPC] 5 0.0000
5 Calcineurin Inhibitor Immunosuppressant [EPC] 5 0.0000
6 Provitamin D2 Compound [EPC] 1 0.0000
7 Interleukin-12 Antagonist [EPC] 3 0.0000
8 Alkylating Drug [EPC] 7 0.0000
9 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
10 Interleukin-6 Receptor Antagonist [EPC] 3 0.0000
11 Mood Stabilizer [EPC] 4 0.0000
12 Tumor Necrosis Factor Blocker [EPC] 16 0.0000
13 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
14 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
16 HER2/neu Receptor Antagonist [EPC] 1 0.0000
17 Topoisomerase Inhibitor [EPC] 1 0.0000
18 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
19 Interferon beta [EPC] 2 0.0000
20 Acetylcholine Release Inhibitor [EPC] 1 0.0000
21 5-alpha Reductase Inhibitor [EPC] 1 0.0000
22 Anti-epileptic Agent [EPC] 2 0.0000
23 Benzodiazepine [EPC] 6 0.0000
24 Platinum-based Drug [EPC] 2 0.0000
25 Nonsteroidal Anti-inflammatory Drug [EPC] 9 0.0000
26 GLP-1 Receptor Agonist [EPC] 3 0.0000
27 Aldosterone Antagonist [EPC] 1 0.0000
28 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
29 Janus Kinase Inhibitor [EPC] 1 0.0000
30 Corticosteroid [EPC] 8 0.0000
31 Microtubule Inhibitor [EPC] 1 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
33 Platelet Aggregation Inhibitor [EPC] 3 0.0000
34 Thiazide Diuretic [EPC] 1 0.0000
35 Atypical Antipsychotic [EPC] 2 0.0000
36 Retinoid [EPC] 1 0.0000
37 Thalidomide Analog [EPC] 2 0.0000
38 Kinase Inhibitor [EPC] 2 0.0000
39 Proton Pump Inhibitor [EPC] 2 0.0000
40 Loop Diuretic [EPC] 1 0.0000
41 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000